Bottom line
THISX vs SHSSX: the short answer
THISX (T. Rowe Price Health Sciences Fund, Inc.) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds.
THISX is cheaper at 0.68% vs 0.86% — a difference of $18 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +4.3% for THISX.
Updated Nov 19, 2026
THISX vs SHSSX side by side
| THISX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.86% |
| Annual cost per $10k | $68 | $86 |
| 10-yr cost on $10k (prospectus) | $847 | $1,061 |
| Max front load | — | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.9% | +16.3% |
| 5-yr return (annualized) | +4.3% | +5.9% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $5.9B |
| Number of holdings | 279 | 155 |
| Portfolio turnover | 62% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of THISX's top 25 holdings also appear in SHSSX's top 25.
| Holding | THISX | SHSSX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 12.29% |
| Johnson & Johnson | 6.63% | 8.77% |
| Unitedhealth Group Inc | 5.99% | 6.10% |
| Abbvie Inc | 5.10% | 3.94% |
| Merck & Co. Inc. | 4.01% | 4.94% |
| Gilead Sciences Inc | 2.82% | 4.19% |
| Thermo Fisher Scientific Inc | 2.52% | 3.02% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.74% |
| Abbott Laboratories | 1.89% | 1.97% |
| Intuitive Surgical Inc | 1.87% | 1.95% |
| Amgen Inc | 1.82% | 3.37% |
| Stryker Corp | 1.78% | 1.15% |
| Elevance Health Inc | 1.53% | 1.56% |
| Danaher Corp | 1.43% | 2.00% |
Source: SEC Form N-PORT
THISX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between THISX and SHSSX?
THISX (T. Rowe Price Health Sciences Fund, Inc.) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both mutual funds. THISX is cheaper at 0.68% vs 0.86% — a difference of $18 a year per $10,000 invested.
Which is cheaper, THISX or SHSSX?
THISX has the lower expense ratio (0.68%).
Should I own both THISX and SHSSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.